BioSpace News Archive

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

Alkermes plc announced the presentation of research related to its psychiatry franchise products—LYBALVI® and ARISTADA® —at four scientific conferences this spring.

May 14, 2024
·
20 min read
Drug Development

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024

Eupraxia Pharmaceuticals Inc. announced that initial results from the ongoing Phase 1b study of EP-104GI for the treatment of eosinophilic esophagitis will be presented at the upcoming Digestive Disease Week Annual Meeting 2024.

May 14, 2024
·
6 min read
Genetown

Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study

Instylla, Inc. today announced the completion of patient enrollment in the ongoing Instylla HES Hypervascular Tumor Pivotal Study.

May 14, 2024
·
2 min read
Business

Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights

Satellos Bioscience Inc. announced today its financial results and operational highlights for the three months ended March 31, 2024.

May 14, 2024
·
9 min read
Genetown

BostonGene Announces Publication and Journal Cover Feature in Cancer Cell that Unveils a New Immune System Profiling Platform Stratifying Cancer Patients by Treatment Response

BostonGene today announced the publication, “Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer” in Cancer Cell.

May 14, 2024
·
5 min read
Business

Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)

Arcadia Biosciences, Inc. announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience.

May 14, 2024
·
2 min read
Genetown

Labster Opens Registration for May 29-30 Science ImmersEd Conference

Labster is introducing Science ImmersEd, a professional development conference for the science educator community.

May 14, 2024
·
4 min read
Drug Development

NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning

NeuroSense Therapeutics announced that it partnered with PhaseV, a pioneer in causal machine learning for clinical trial analysis and optimization, with respect to the planned Phase 3 trial of PrimeC as a treatment for amyotrophic lateral sclerosis.

May 14, 2024
·
6 min read
Business

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2024.

May 14, 2024
·
10 min read
Business

Anumana Appoints Harry S. Palmin as CFO

Anumana today announced the appointment of Harry S. Palmin as chief financial officer (CFO).

May 14, 2024
·
5 min read